Cell-based therapy for heart failure: Skeletal myoblasts

Cell Transplantation

Volumn 18, Issue 7, 2009, Pages 695-707

  Seidel, Monika ^a   Borczyńska, Aleksandra ^a   Rozwadowska, Natalia ^a   Kurpisz, Maciej ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

Myoblast therapy; Myocardium regeneration; Stem cells

Indexed keywords

FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SCATTER FACTOR; VASCULOTROPIN;

ADJUVANT THERAPY; ANGIOGENESIS; AUTOGRAFT; BLAST TRANSFORMATION; CELL DIFFERENTIATION; CELL RENEWAL; CELL SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY BYPASS GRAFT; ENGRAFTMENT; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MICROENVIRONMENT; MONOTHERAPY; MUSCLE REGENERATION; MYOBLAST; MYOBLAST TRANSPLANTATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE SATELLITE CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

BONE MARROW CELLS; CARDIOMYOPATHIES; CELL DIFFERENTIATION; CELL SURVIVAL; HEART; HEART FAILURE; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 70350633745     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X470810     Document Type: Review

References (70)

1. Abraham, M. R.; Henrikson, C. A.; Tung, L.; Chang, M. G.; Aon, M.; Xue, T.; Li, R. A.; O'Rourke, B.; Marban, E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 97:159-167; 2005.
2. + progenitors for the repair of infarcted myocardium. J. Am. Coll. Cardiol. 44: 458-463; 2004.
3. Askari, A.; Unzek, S.; Goldman, C. K.; Ellis, S. G.; Thomas, J. D.; DiCorleto, P. E.; Topol, E. J.; Penn, M. S. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J. Am. Coll. Cardiol. 43:1908-1914; 2004.
4. Assmus, B.; Schäuchinger, V.; Teupe, C.; Britten, M.; Lehman, R.; Dobert, N.; Grunwald, F.; Aicher, A.; Urbich, C.; Martin, H.; Hoelzer, D.; Dimmeler, S.; Zeiher, A. M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017; 2002. (Pubitemid 35440281)
5. Azarnoush, K.; Maurel, A.; Sebbah, L.; Carrion, C.; Bissery, A.; Mandet, C.; Pouly, J.; Bruneval, P.; Hagège, A.; Menasché, P. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia- inducible factors 1α. J. Thorac. Cardiovasc. Surg. 130:173-179; 2005.
6. Biagini, E.; Valgimigli, M.; Smits, P. C.; Poldermans, D.; Schinkel, A. F.; Rizzello, V.; Onderwater, E. E.; Bountioukos, M.; Serruys, P. W. Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur. J. Heart Fail. 8:641-648; 2006.
7. Chachques, J. C.; Duarte, F.; Cattadori, B.; Shafy, A.; Lila, N.; Chatellier, G.; Fabiani, J. N.; Carpentier, A. F. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study. J. Thorac. Cardiovasc. Surg. 128:245-253; 2004.
8. Chachques, J. C.; Herreros, J.; Trainini, J.; Juffe, A.; Rendal, E.; Prosper, F.; Genovese, J. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol. 95(Suppl.):S29-S33; 2004.
9. Cossu, G.; Mavilio, F. Myogenic stem cells for the therapy of primary myopathies: Wishful thinking or therapeutic perspective? J. Clin. Invest. 105:1669-1674; 2000.
10. Dib, N. First United States randomized controlled trial utilizing 3-dimensional guided, catheter-based delivery of autologous skeletal myoblasts for ischaemic cardiomyopathy: Feasibility, safety and improvement in cardiac performance. American College of Cardiology 56th Annual Scientific Session, New Orleans, LA; 2007.
11. Dib, N.; McCarthy, P.; Campbell, A. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant. 14:11-19; 2005.
12. Dudley, S. C. Beware of cells bearing gifts: Cell replacement therapy and arrhythmic risk. Circ. Res. 97:99-101; 2005.
13. Fernandez-Cobo, M.; Gingalewski, C.; Drujan, D.; De Maio, A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumor necrosis factor. Cytokine 11:216-224; 1999.
14. Formigli, L.; Francini, F.; Tani, A.; Squecco, R.; Nosi, D.; Polidori, L.; Nistri, S.; Chiappini, L.; Cesati, V.; Pacini, A.; Perna, A. M.; Orlandini, G. E.; Orlandini, S. Z.; Bani, D. Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am. J. Physiol. Cell. Physiol. 288:795-804; 2005.
15. Ghostine, S.; Carrion, C.; Souza, L. C. G.; Richard, P.; Bruneval, P.; Vilquin, J. T.; Pouzet, B.; Schwartz, K.; Menasché, P.; Hagège, A. A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106(Suppl. I): I131-136; 2002.
16. Grounds, M. D.; White, J. D.; Rosenthal, N.; Bogoyevitch, M. A. The role of stem cells in skeletal and cardiac muscle repair. J. Histochem. Cytochem. 50:589-610; 2002.
17. Hagège, A. A.; Carrion, C.; Menasché, P.; Vilquin, J. T.; Duboc, D.; Marolleau, J. P.; Desnos, M.; Bruneval, P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyophathy. Lancet 361:491-492; 2003. (Pubitemid 36173717)
18. Hermonat, P. L.; Mehta, J. L. Potential of gene therapy for myocardial ischemia. Curr. Opin. Cardiol. 19:517-523; 2004.
19. Herreros, J.; Prosper, F.; Perez, A.; Gavira, J. J.; Garcia-Velloso, M. J.; Barba, J.; Sanchez, P. L.; Canizo, C.; Rabago, G.; Marti-Climent, J. M.; Hernandez, M.; Lopez-Holgado, N.; Gonzalez-Santos, J. M.; Martin-Luengo, C.; Alegria, E. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24:2012- 2020; 2003.
20. Hutcheson, K. A.; Atkins, B. Z.; Hueman, M. T.; Hopkins, M. B.; Glower, D. D.; Taylor, D. A. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 9:359-368; 2000.
21. Ince, H.; Petzsch, M.; Rehders, T. C.; Kische, S.; Chatterjee, T.; Nienaber, C. A. Percutaneous transplantation of autologous myoblasts in ischemic cardiomyopathy. Herz 30:223-231; 2005.
22. Jain, M.; DerSimonian, H.; Brenner, D. A.; Ngoy, S.; Teller, P.; Edge, A. S. B.; Zawadzka, A.; Wetzel, K.; Sawyer, D. B.; Colucci, W. S.; Apstein, C. S.; Liao, R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infraction. Circulation 103:1920-1927; 2001.
23. Kurpisz, M.; Czepczyński, R.; Grygielska, B.; Majewski, M.; Fiszer, D.; Jerzykowska, O.; Sowiński, J.; Siminiak, T. Bone marrow stem cell imaging after intracoronary administration. Int. J. Cardiol. 121:194-195; 2007.
24. Law, P. K.; Haider, K.; Fang, G.; Jiang, S.; Chua, F.; Lim, Y. T.; Sim, E. Human VEGF165- myoblasts produce concomitant angiogenesis/myogenesis in the regenerative heart. Mol. Cell. Biochem. 263:173-178; 2004.
25. Léobon, B.; Garcin, I.; Menasché, P.; Vilquin, J. T.; Audinat, E.; Charpak, S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. USA 100:7808-7811; 2003.
26. Makkar, R. R.; Lill, M.; Chen, P. S. Stem cell therapy for myocardial repair. J. Am. Coll. Cardiol. 42:2070-2072; 2003.
27. Marelli, D.; Ma, F.; Chiu, R. C. Satellite cell implantation for neomyocardial regeneration. Transplant. Proc. 24:2995; 1992.
28. Maurel, A.; Azarnoush, K.; Sabbah, L.; Vignier, N.; Le Lorc'h, M.; Mandet, C.; Bissery, A.; Garcin, I.; Carrion, C.; Fiszman, M.; Bruneval, P.; Hagège, A.; Carpentier, A.; Vilquin, J. T.; Menasché, P. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 80:660-665; 2005.
29. Mauro, A. Satellite cells of skeletal muscle fibers. J. Biochem. Biophys. Cytol. 9:493-498; 1961.
30. Memon, I. A.; Sawa, Y.; Fukushima, N.; Matsumiya, G.; Miyagawa, S.; Taketani, S.; Sakakida, S. K.; Kondoh, H.; Sakakida, S.; Kaleshin, A. N.; Shimizu, T.; Okano, T.; Matsuda, H. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J. Thorac. Cardiovasc. Surg. 130:1333-1341; 2005.
31. Menasché, P. Cell transplantation in myocardium. Ann. Thorac. Surg. 75:20-28; 2003.
32. Menasché, P. Skeletal muscle satellite cell transplantation. Cardiovasc. Res. 58:351-357; 2003.
33. Menasché, P. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. First randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200; 2008.
34. Menasché, P.; Desnos, M. Cardiac reparation: Fixing the heart with cells, new vessels and genes. Eur. Heart J. Suppl. 4:D73-D81; 2002.
35. Menasché, P.; Hagège, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfraction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:1078-1083; 2003.
36. Oh, H.; Bradfute, S. B.; Gallardo, T. D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L. H.; Behringer, R. R.; Garry, D. J.; Entman, M. L.; Schneider, M. D. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100:12313-12318; 2003.
37. Pagani, F. D.; DerSimonian, H.; Zawadzka, A.; Wetzel, K.; Edge, A. S. B.; Jacoby, D. B.; Dinsmore, J. H.; Wright, S.; Aretz, T. H.; Eisen, H. J.; Aaronson, K. D. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41: 879-888; 2003.
38. Patel, A. N.; Spadaccio, C.; Kuzman, M.; Park, E.; Fisher, D. W.; Stice, S. L.; Mullangi, C.; Toma, C. Improved cell survival in infarcted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplant. 16:899-905; 2007.
39. Pouly, J.; Hagège, A. A.; Vilquin, J. T.; Bissery, A.; Rouche, A.; Bruneval, P.; Duboc, D.; Desnos, M.; Fiszman, M.; Fromes, Y.; Menasché, P. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 110:1626-1631; 2004.
40. Pouzet, B.; Ghostine, S.; Vilquin, J. T.; Garcin, I.; Scorsin, M.; Hagège, A. A.; Duboc, D.; Schwartz, K.; Menasché, P. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin- converting enzyme inhibitors? Circulation 104(Suppl.):I223-228; 2001.
41. Pouzet, B.; Vilquin, J. T.; Hagège, A. A.; Scorsin, M.; Messas, E.; Fiszman, M.; Schwartz, K.; Menasché, P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71:844-851; 2001.
42. Premaratne, G. U.; Tambara, K.; Fujita, M.; Lin, X.; Kanemitsu, N.; Tomita, S.; Sakaguchi, G.; Nakajima, H.; Ikeda, T.; Komeda, M. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ. J. 70:1184-1189; 2006. (Pubitemid 44387002)
43. Reinecke, H.; MacDonald, G. H.; Hauschka, S. D.; Murry, C. E. Electromechanical coupling between skeletal and cardiac muscle: Implications for infarct repair. J. Cell. Biol. 149:731-740; 2000.
44. Reinecke, H.; Minami, E.; Virag, J. I.; Murry, C. E. Gene transfer of connexin43 into skeletal muscle. Hum. Gene Ther. 15:627-636; 2004.
45. Reinecke, H.; Poppa, V.; Murry, C. E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34:241-249; 2002.
46. Sawa, Y.; Memon, I.; Miyamoto, Y.; Taketani, S.; Miyagawa, S.; Kondob, H.; Sbimizu, T.; Okano, T.; Matsuda, H. Tissue implantation with autologous myoblast sheet improved cardiac performance in the impaired myocardium. J. Heart Lung. Transplant. 23(2S):346; 2004.
47. Serruys, P. W. Safety and effects of implanted (autologous) skeletal myoblasts using an injection catheter: The SEISMIC study. Third International Conference on Cell Therapy for Cardiovascular Disease, New York, NY; 2007.
48. Sherman, W. Myocyte replacement therapy: Skeletal myoblasts. Cell Transplant. 16:971-975; 2007.
49. Sherman, W.; Chronos, N.; Ellis, S.; Henry, T.; Holmes, D. Intramyocardial myoblast treatment for ischemic heart failure: Results of a phase 1 study. J. Cardiac Fail. 12(6, Suppl. 1):S74; 2006.
50. Siminiak, T.; Fiszer, D.; Jerzykowska, O.; Grygielska, B.; Rozwadowska, N.; Kałmucki, P.; Kurpisz, M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. Eur. Heart J. 26:1188-1195; 2005.
51. Siminiak, T.; Kalawski, R.; Fiszer, D.; Jerzykowska, O.; Rzeźniczak, J.; Rozwadowska, N.; Kurpisz, M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. 148:531-537; 2004.
52. Siminiak, T.; Kurpisz, M. Myocardial replacement therapy. Circulation 108:1167-1171; 2003.
53. Smits, P. C.; van Geuns, R. J.; Poldermans, D.; Bountioukos, M.; Onderwater, E. E. M.; Lee, C. H.; Maat, A. P. W. M.; Serruys, P. W. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42: 2063-2069; 2003.
54. Suzuki, K.; Brand, N. J.; Allen, S.; Khan, M. A.; Farrell, A. O.; Martuza, B.; El Oakley, R.; Yacoub, M. H. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. Surg. 122:759-766; 2001.
55. Suzuki, K.; Murtuza, B.; Beauchamp, J. R.; Brand, N. J.; Barton, P. J. R.; Varela-Carver, A.; Fukushima, S.; Coppen, S. R.; Partridge, T. A.; Yacoub, M. H. Role of interleukin-1β in acute inflammation and graft death after cell transplantation to the heart. Circulation 110(Suppl. II):II219- 224; 2004.
56. Suzuki, K.; Murtuza, B.; Smoleński, R. T.; Sammut, I. A.; Suzuki, N.; Kanada, Y.; Yacoub, M. H. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104(Suppl. I):I207-212; 2001.
57. Suzuki, K.; Murtuza, B.; Suzuki, N.; Smolenski, R. T.; Yacoub, M. H. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 104:I213-I217; 2001.
58. Suzuki, K.; Smolenski, R. T.; Jayakumar, J.; Martuza, B.; Brand, N. I.; Yacoub, M. H. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102(Suppl. III):III216-221; 2000.
59. Tambara, K.; Tabata, Y.; Komeda, M. Factors related to the efficacy of skeletal muscle cell transplantation and future approaches with control-released cell growth factors and minimally invasive surgery. Int. J. Cardiol. 95:S13-S15; 2004.
60. Taylor, D. A. Cell-based myocardial repair: How should we proceed? Int. J. Cardiol. 95(Suppl.):S8-S12; 2004.
61. Tolmachov, O.; Ma, Y. L.; Themis, M.; Patel, P.; Spohr, H.; MacLeod, K. T.; Illrich, N. D.; Kienast, Y.; Coutelle, C.; Peters, N. S. Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro. BMC Cardiovasc. Disord. 6:25; 2006.
62. Unzek, S.; Zhang, M.; Mal, N.; Mills, W. R.; Laurita, K. R.; Penn, M. S. SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant. 16:879-886; 2007.
63. Xia, J. H.; Xie, A. N.; Zhang, K. L.; Xu, L.; Zheng, X. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin. Med. J. 119:117-121; 2006.
64. Yau, T. M.; Kim, C.; Ng, D.; Li, G.; Zhang, Y.; Weisel, R. D.; Li, R. K. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann. Thorac. Surg. 80:1779-1786; 2005.
65. Yau, T. M.; Li, G.; Weisel, R. D.; Reheman, A.; Jia, Z. Q.; Mickle, D. A. G.; Li, R. K. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J. Thorac. Cardiovasc. Surg. 127:1180-1187; 2004.
66. Ye, L.; Haider, H. K.; Jiang, S.; Ge, R.; Law, P. K.; Sim, E. K. W. In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1. J. Heart Lung Transplant. 24:1393-1402; 2005.
67. Ye, L.; Haider, H. K.; Jiang, S.; Ling, L. H.; Ge, R.; Law, P. K.; Sim, E. K. W. Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model. Eur. J. Heart Fail. 7:945-952; 2005.
68. Ye, L.; Haider, H. K.; Sim, E. K. W. Adult stem cells for cardiac repair: A choice between skeletal myoblasts and bone marrow stem cells. Exp. Biol. Med. 231:8-19; 2006.
69. Yoo, K. J.; Li, R. K.; Weisel, R. D.; Mickle, D. A. G.; Li, G.; Yau, T. M. Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann. Thorac. Surg. 70:859-865; 2000.
70. Zhang, F.; Yang, Z.; Chen, Y.; Qin, J.; Zhu, T.; Xu, D.; Xu, Z.; Xu, Q.; Qian, Y.; Ma, W.; Chen, L.; Gao, X.; Li, C.; Ha, T.; Kao, R. L. Clinical cellular cardiomyoplasty: Technical considerations. J. Card. Surg. 18:268-273; 2003.